Leo Li‐Ying Chan

ORCID: 0000-0003-2011-4278

Also affiliated with Wave Life Sciences (United States), Greater Lawrence Family Health Center

Biochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer”.

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.624498

N/A

0.495DataRank · unranked

9 citations

Stephanie Sullivan, Leo Li‐Ying Chan, Yajie Yin, Wenchuan Sun, Ziwei Fang +4 more

Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometry

Journal of Immunological Methods(2020)10.1016/j.jim.2020.112830

N/A

0DataRank · unranked

10 citations

Andrea C. Love, Kevin Tosh, Leo Li‐Ying Chan, Kevin Gayout, Tim Smith +2 more

High-throughput viral microneutralization method for feline coronavirus using image cytometry

Journal of Virological Methods(2020)10.1016/j.jviromet.2020.113979

N/A

0DataRank · unranked

6 citations

Alora LaVoy, Leo Li‐Ying Chan, Gregg A. Dean, Morgan Pearson